IgG N‐glycans are associated with prevalent and incident complications of type 2 diabetes

Abstract

AbstractAims/HypothesisInflammation is important in the development of type 2 diabetes complications. The N‐glycosylation of IgG influences its role in inflammation. To date, the association of plasma IgG N‐glycosylation with type 2 diabetes complications has not been extensively investigated. We hypothesised that N‐glycosylation of IgG may be related to the development of complications of type 2 diabetes.MethodsIn three independent type 2 diabetes cohorts, plasma IgG N‐glycosylation was measured using ultra performance liquid chromatography (DiaGene n = 1815, GenodiabMar n = 640) and mass spectrometry (Hoorn Diabetes Care Study n = 1266). We investigated the associations of IgG N‐glycosylation (fucosylation, galactosylation, sialylation and bisection) with incident and prevalent nephropathy, retinopathy and macrovascular disease using Cox‐ and logistic regression, followed by meta‐analyses. The models were adjusted for age and sex and additionally for clinical risk factors.ResultsIgG galactosylation was negatively associated with prevalent and incident nephropathy and macrovascular disease after adjustment for clinical risk factors. Sialylation was negatively associated with incident diabetic nephropathy after adjustment for clinical risk factors. For incident retinopathy, similar associations were found for galactosylation, adjusted for age and sex.ConclusionsWe showed that IgG N‐glycosylation, particularly galactosylation and to a lesser extent sialylation, is associated with a higher prevalence and future development of macro‐ and microvascular complications of diabetes. These findings indicate the predictive potential of IgG N‐glycosylation in diabetes complications and should be analysed further in additional large cohorts to obtain the power to solidify these conclusions.